MONDAY, Sept. 16, 2024 -- The risk for firearm reinjury among children who present with acute nonfatal firearm injury is 6 and 14 percent at one and...

MONDAY, Sept. 23, 2024 -- The incidence of a composite cardiovascular disease (CVD) end point is increased among older adults with cancer, especially...

MONDAY, Sept. 16, 2024 -- Most nicotine brand Instagram posts do not adhere to U.S. Food and Drug Administration (FDA) health warning requirements for...

MONDAY, Sept. 16, 2024 -- Among youth with chronic pain, a number of individuals are diagnosed with anxiety and depression when compared with their...

MONDAY, Sept. 16, 2024 -- The U.S. Food and Drug Administration has approved Tremfya (guselkumab) for the treatment of adults with moderately to...

MONDAY, Sept. 16, 2024 -- The U.S. Food and Drug Administration has approved Tremfya (guselkumab) for the treatment of adults with moderately to...

TUESDAY, Sept. 24, 2024 -- Long-term use of skeletal muscle relaxants (SMRs) for chronic pain is only effective for certain conditions, such as...

THURSDAY, Sept. 26, 2024 -- Gamified digital mental health interventions (DMHIs) may offer benefits for youth with attention-deficit/hyperactivity...

MONDAY, Sept. 16, 2024 -- For patients undergoing treatment for certain types of cancer, artificial intelligence (AI) can use electrocardiographic...

WEDNESDAY, Sept. 18, 2024 -- Monthly use of erenumab injections (140 mg) is safe and effective in achieving medication overuse headache (MOH)...